Document Detail


Are angiotensin-converting enzyme inhibitors and beta-blockers making an impact on the epidemiology of heart failure?
MedLine Citation:
PMID:  15075049     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
With the advent of the 21st century, heart failure has emerged as a major component of the massive public health problem of cardiovascular disease. Currently over 5 million Americans suffer from the syndrome of heart failure with significant direct treatment costs estimated to be in excess of $22 billion per year. Unfortunately, assuming present demographic and medical trends continue, these bleak statistics are expected to worsen substantially over the next two decades. Epidemiologic studies have furthered our mechanistic understanding of heart failure pathophysiology by demonstrating that many patients with this syndrome have preserved systolic function by standard indices. In a positive turn, major advances have occurred in the treatment of heart failure based on the development of clinically effective pharmacologic antagonists of the renin-angiotensin-aldosterone and sympathetic nervous systems. These agents are capable of substantially reducing the morbidity and mortality associated with heart failure. However, the importance of enhanced physician and public awareness of heart failure remains critical in the future.
Authors:
Kirkwood F Adams
Related Documents :
17922619 - Novel cardiac myosin activators for acute heart failure.
24713529 - Volume of carotid artery ulceration as a predictor of cardiovascular events.
9412539 - Molecular and cellular mechanisms of myocardial failure.
16283969 - Aldosterone antagonists in the treatment and prevention of heart failure.
18313629 - Optimal treatment of hypertension with diastolic heart failure.
8772689 - Prognostic significance of plasma norepinephrine in patients with asymptomatic left ven...
25484029 - Atrial dominance in the human embryonic heart - a study of cardiac function at 6-10 wee...
2488099 - The use of digitalis for the treatment of congestive heart failure: a tale of its decli...
3723779 - Clinical evidence suggesting vasospastic cause of myocardial infarction.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current cardiology reports     Volume:  6     ISSN:  1523-3782     ISO Abbreviation:  Curr Cardiol Rep     Publication Date:  2004 May 
Date Detail:
Created Date:  2004-04-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100888969     Medline TA:  Curr Cardiol Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  162-8     Citation Subset:  IM    
Affiliation:
University of North Carolina Heart Failure Program, 6110 Falconbridge Road, Suite 101, Chapel Hill, NC 27517, USA. kfa@med.unc.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Erythromelalgia.
Next Document:  Is too much neurohormonal blockade harmful?